Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03029598
Title Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Washington
Indications

fallopian tube cancer

peritoneum cancer

ovarian cancer

Therapies

Carboplatin + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.